Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
1.880
-0.110 (-5.53%)
At close: Nov 13, 2026, 4:00 PM EST
1.875
-0.005 (-0.27%)
After-hours: Nov 13, 2026, 7:30 PM EST
Fortress Biotech Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 100.12 | 6.82 | -46 | -60.64 | -86.58 | -64.7 |
Depreciation & Amortization | 4.51 | 4.66 | 4.46 | 6 | 7.39 | 6.79 |
Other Amortization | 2.09 | 1.4 | 2.05 | 3.03 | 2.07 | 3.91 |
Loss (Gain) From Sale of Assets | -0.19 | -27.13 | 0.03 | 2.66 | 0.26 | - |
Asset Writedown & Restructuring Costs | 0.11 | - | 3.94 | 7.47 | 0.64 | 15.63 |
Loss (Gain) From Sale of Investments | -11.79 | -15.08 | -0.74 | 0.76 | - | -36.45 |
Stock-Based Compensation | 9.24 | 28.74 | 32.62 | 17.03 | 22.99 | 19.49 |
Provision & Write-off of Bad Debts | 0.04 | -0.21 | 0.52 | 0.44 | 0.28 | 0.05 |
Other Operating Activities | 32.99 | -39.89 | -68.95 | -92.45 | -125.73 | -97.63 |
Change in Accounts Receivable | -29.44 | -19.34 | 4.48 | 12.55 | -5.38 | 0.77 |
Change in Inventory | 4.05 | 4.81 | -4.23 | 3.95 | 1.74 | -8.46 |
Change in Accounts Payable | 12.29 | -7.97 | -6.39 | -24.38 | 8.35 | 43.31 |
Change in Unearned Revenue | - | - | - | - | -1.88 | 2.61 |
Change in Income Taxes | 4.11 | -0.58 | 0.09 | 0.12 | 0.38 | 0.35 |
Change in Other Net Operating Assets | -2.3 | -2.02 | -2.08 | -4.76 | -3.92 | -2.2 |
Operating Cash Flow | 125.83 | -65.78 | -80.19 | -128.23 | -179.4 | -116.54 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.09 | - | - | -0.06 | -2.72 | -4.57 |
Sale of Property, Plant & Equipment | - | 1.17 | - | 6 | 0.13 | - |
Divestitures | - | 8.96 | - | - | - | 56.86 |
Sale (Purchase) of Intangibles | - | - | -15 | -8.04 | -20.34 | -11.78 |
Other Investing Activities | - | - | - | -0.01 | - | - |
Investing Cash Flow | -0.09 | 10.12 | -15 | -2.1 | -22.93 | 40.51 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | - | - | 28 | 5 | 7 |
Long-Term Debt Issued | - | - | 43.67 | 14.53 | 47.11 | - |
Total Debt Issued | - | - | 43.67 | 42.53 | 52.11 | 7 |
Short-Term Debt Repaid | - | - | - | -30.95 | -2.86 | -6.19 |
Long-Term Debt Repaid | - | -0.7 | -1.25 | -51.38 | -5 | -15.75 |
Total Debt Repaid | 0.06 | -0.7 | -1.25 | -82.32 | -7.86 | -21.94 |
Net Debt Issued (Repaid) | 0.06 | -0.7 | 42.42 | -39.79 | 44.25 | -14.94 |
Issuance of Common Stock | 2.2 | 3.96 | 22.23 | 24.8 | 6.72 | 9.37 |
Repurchase of Common Stock | - | - | - | - | -1.7 | - |
Preferred Dividends Paid | - | - | -4.02 | -8.03 | -8.03 | -8.03 |
Dividends Paid | - | - | -4.02 | -8.03 | -8.03 | -8.03 |
Other Financing Activities | -47.7 | 74.45 | 10.01 | 56.17 | 34.17 | 162.59 |
Financing Cash Flow | -59.78 | 77.44 | 70.64 | 32.74 | 75.32 | 148.99 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 65.97 | 21.79 | -24.55 | -97.59 | -127.01 | 72.97 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 125.75 | -65.78 | -80.19 | -128.29 | -182.12 | -121.11 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | 179.66% | -103.98% | -139.04% | -151.80% | -240.44% | -176.05% |
Free Cash Flow Per Share | 3.67 | -2.36 | -3.86 | -15.82 | -30.74 | -22.23 |
Levered Free Cash Flow | -26.07 | -47.29 | -53.06 | -98.15 | -118.4 | -67.29 |
Unlevered Free Cash Flow | -22.3 | -42.37 | -48.91 | -91.62 | -111.94 | -61.64 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 6.65 | 7.39 | 7.16 | 7.95 | 9.42 | 6.92 |
Cash Income Tax Paid | 0.16 | 0.05 | 0.12 | -0.06 | 0.86 | 0.99 |
Change in Working Capital | -11.29 | -25.1 | -8.13 | -12.52 | -0.72 | 36.37 |